Prospective Study of AI H5N1 in China
NCT00428493 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2008-05-30
Summary
The purpose of this study is to see if people in China who have contact with someone infected with bird flu (H5N1) become infected themselves without necessarily getting sick. Adults and children greater than 1 year of age who have contact with someone infected with bird flu may participate in the study. At the first 1-2 study visits, a blood sample will be taken from volunteers in order to test for antibodies, the part of the blood that fights infection. If the result of the H5N1 antibody test is positive after the 1st or 2nd study visit, an additional blood sample will be collected during a 3rd and 4th study visit. Volunteers will be asked questions about their work, home life, and possible contact with poultry, other birds, animals, and people infected with bird flu. Participants will be involved in study related procedures for up to 90 days.
Conditions
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Eligibility
- Min Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Completion
- 2008-01-31
Countries
- China
Study Locations
More Related Trials
-
Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups
NCT00711295 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
NCT01443663 ·Status: COMPLETED ·Phase: PHASE1
-
Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine
NCT00311727 ·Status: COMPLETED ·Phase: NA
-
Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults
NCT00347672 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Avian Flu Vaccine
NCT00408109 ·Status: COMPLETED ·Phase: PHASE1
-
Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses
NCT00417560 ·Status: WITHDRAWN ·Phase: NA
-
Inactivated Influenza A/H5N1 Vaccine in the Elderly
NCT00230750 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults
NCT01776541 ·Status: COMPLETED ·Phase: PHASE2
-
A/H5N1 Dose Ranging Study With Adjuvant Patch
NCT00532792 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
NCT01045564 ·Status: WITHDRAWN ·Phase: PHASE2
-
Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities
NCT00311649 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older
NCT01774032 ·Status: COMPLETED ·Phase: PHASE3
-
A/H5N1in Adult - Aventis
NCT00115986 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
NCT00489931 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine
NCT00535665 ·Status: COMPLETED ·Phase: PHASE2
-
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)
NCT01551810 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
NCT01766921 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents
NCT01052402 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine
NCT00660257 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine
NCT01675284 ·Status: COMPLETED ·Phase: PHASE1
-
H5N1 Vaccine Study in Japanese Adults
NCT01382329 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
NCT00462215 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
NCT02839330 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)
NCT00110279 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines
NCT00478816 ·Status: COMPLETED ·Phase: PHASE2